Barclays Initiates Coverage On BorgWarner with Overweight Rating, Announces Price Target of $62
Barclays analyst Dan Levy initiates coverage on BorgWarner (NYSE:BWA) with a Overweight rating and announces Price Target of $62.
Barclays Initiates Coverage On Ford Motor with Equal-Weight Rating, Announces Price Target of $13
Barclays analyst Dan Levy initiates coverage on Ford Motor (NYSE:F) with a Equal-Weight rating and announces Price Target of $13.
Barclays Initiates Coverage On Lion Electric with Equal-Weight Rating, Announces Price Target of $3
Barclays analyst Dan Levy initiates coverage on Lion Electric (NYSE:LEV) with a Equal-Weight rating and announces Price Target of $3.
Barclays Initiates Coverage On Mobileye Global with Overweight Rating, Announces Price Target of $60
Barclays analyst Dan Levy initiates coverage on Mobileye Global (NASDAQ:MBLY) with a Overweight rating and announces Price Target of $60.
RBC Capital Assumes Frontier Lithium at Outperform, Announces Price Target of C$3.75
RBC Capital analyst Wayne Lam assumes Frontier Lithium (TSXV:FL) with a Outperform rating and announces Price Target of C$3.75.
Goldman On Cybersecurity Stocks: Bullish On Palo Alto, Bearish On Cloudflare, Plus More Ratings
Investment banking giant Goldman Sachs Group Inc (NYSE: GS) made a major move in the security sector, initiating coverage of several companies with Buy, Neutral and Sell ratings.
Credit Suisse Initiates Coverage On Crescent Energy with Neutral Rating, Announces Price Target of $14
Credit Suisse analyst William Janela initiates coverage on Crescent Energy (NYSE:CRGY) with a Neutral rating and announces Price Target of $14.
Citigroup Initiates Coverage On Grupo Televisa with Buy Rating, Announces Price Target of $8.5
Citigroup analyst Andres Cardona initiates coverage on Grupo Televisa (NYSE:TV) with a Buy rating and announces Price Target of $8.5.
Cowen & Co. Initiates Coverage On Keros Therapeutics with Outperform Rating
Cowen & Co. analyst Tyler Van Buren initiates coverage on Keros Therapeutics (NASDAQ:KROS) with a Outperform rating.
JMP Securities Initiates Coverage On Terns Pharma with Market Outperform Rating, Announces Price Target of $17
JMP Securities analyst Silvan Tuerkcan initiates coverage on Terns Pharma (NASDAQ:TERN) with a Market Outperform rating and announces Price Target of $17.